Inspire Medical Systems, Inc. Common Stock (INSP)
77.77
-10.14 (-11.53%)
NYSE · Last Trade: Aug 6th, 2:58 PM EDT
Detailed Quote
Previous Close | 87.91 |
---|---|
Open | 87.82 |
Bid | 77.76 |
Ask | 77.78 |
Day's Range | 77.05 - 87.82 |
52 Week Range | 73.92 - 225.00 |
Volume | 2,296,490 |
Market Cap | 2.12B |
PE Ratio (TTM) | 47.71 |
EPS (TTM) | 1.6 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,115,136 |
Chart
About Inspire Medical Systems, Inc. Common Stock (INSP)
Inspire Medical Systems is a medical device company focused on developing innovative solutions to treat obstructive sleep apnea. The company specializes in the design and manufacturing of implantable neurostimulation devices that work to improve airflow during sleep by stimulating the hypoglossal nerve, which helps keep the airway open. Their technology aims to provide an effective alternative for individuals who are unable to tolerate traditional continuous positive airway pressure (CPAP) therapy. Through its pioneering approach, Inspire Medical Systems is committed to enhancing the quality of life for patients with sleep-disordered breathing conditions. Read More
News & Press Releases
US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down & Fed may cut rates.
Via Benzinga · August 6, 2025
Via Benzinga · August 6, 2025
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · August 5, 2025
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversoldstocktwits.com
Via Stocktwits · August 5, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · August 5, 2025
Via Benzinga · August 5, 2025
Inspire Medical stock falls as Q2 earnings beat is overshadowed by guidance cut and slower U.S. rollout of its newly approved Inspire V system.
Via Benzinga · August 5, 2025
Shares of medical technology company Inspire Medical Systems (NYSE:INSP)
fell 41.3% in the afternoon session after the company slashed its full-year revenue and profit forecasts, a move that overshadowed a second-quarter earnings beat.
Via StockStory · August 5, 2025
Via Benzinga · August 5, 2025
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 5, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · August 5, 2025
The company makes implantable devices for sleep apnea, an area Eli Lilly is marketing its weight-loss drug.
Via Investor's Business Daily · August 5, 2025
Via Benzinga · August 5, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via Chartmill · August 5, 2025
Via Benzinga · August 5, 2025
Via Benzinga · August 5, 2025
Via Benzinga · August 5, 2025
Medical technology company Inspire Medical Systems (NYSE:INSP) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.8% year on year to $217.1 million. On the other hand, the company’s full-year revenue guidance of $905 million at the midpoint came in 4.6% below analysts’ estimates. Its GAAP loss of $0.12 per share was significantly below analysts’ consensus estimates.
Via StockStory · August 4, 2025
Via Benzinga · August 4, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · August 4, 2025
Inspire Medical Systems (NYSE:INSP) offers strong growth, fair valuation, and solid financial health, making it an ideal pick for affordable growth investors.
Via Chartmill · August 4, 2025